Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 08/06/20181 min de leitura
Development of Inhaled Antibacterial Drugs for Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis; Public Workshop; Request for Comments
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Development of Inhaled Antibacterial Drugs for Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis." The purpose of the public workshop is to discuss the clinical trial design challenges and future considerations for inhaled antibacterial products to treat cystic fibrosis (CF) and non-CF bronchiectasis.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →